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Abstract The SERPINE1 (serpin peptidase inhibitor,
clade E, member 1) gene, better known by its previous
symbol PAI-1 (plasminogen activator inhibitor 1), has been
associated with cardiovascular phenotypes with differing
results. Our aim was to examine the association between
the rs6950982 (G [ A) near the SERPINE1 gene, blood
pressure (BP) and plasma lipid concentrations as well as
the modulation of the polymorphism effects by adherence
to Mediterranean diet (AMD). We studied 945 high-car-
diovascular-risk subjects. Biochemical, clinical, dietary
and genetic data (rs6950982) were obtained. We also
determined the common rs1799768 (4G/5G), for checking
independent effects. AMD was measured by a validated
questionnaire, and four groups were considered. rs6950982
(A [ G) and rs1799768 (4G/5G) were only in moderate–
low linkage disequilibrium (D0 = 0.719; r2 = 0.167). The
most significant associations we obtained were with
rs6950982 (A [ G). In males, the G allele was nominally
associated with higher diastolic BP (AA: 81.5 ± 10.9, AG:
82.1 ± 11.4, GG: 85.7 ± 10.5 mmHg; Padditive = 0.030)
and systolic BP (AA ? AG: 141.4 ± 6.9 mmHg vs. GG:
149.8 ± 8.0 mmHg; Precessive = 0.036). In the whole
population, the rs6950982 was also associated with plasma
lipids. Subject with the G allele presented higher total
cholesterol (Padditive = 0.016, Precessive = 0.011), low-
density lipoprotein cholesterol (Padditive = 0.032,
Precessive = 0.031) and triglycerides (Padditive = 0.040,
Precessive = 0.029). AMD modulated the effect of
rs6950982 on triglyceride concentrations (P for interac-
tion = 0.036). Greater AMD reduced the higher triglyc-
eride concentrations in GG subjects. No significant
interactions were found for the other parameters. The
rs6950982 was associated with higher BP in men and
higher triglycerides in the whole population, this associa-
tion being modulated by AMD.
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Introduction
Several studies have demonstrated that a higher adherence
to the Mediterranean diet has a beneficial effect on car-
diovascular diseases (Trichopoulou et al. 2003; Buckland
et al. 2009; Fung et al. 2009; Martı´nez-Gonza´lez et al.
2011). In a pilot study (Estruch et al. 2006), we have shown
that after a 3-month intervention with Mediterranean diet,
this intervention produced beneficial changes in several
cardiovascular risk factors compared with a low-fat diet.
Outstanding among them were the significant reductions in
systolic and diastolic blood pressure (BP). We also
observed favorable changes in plasma lipids (Estruch et al.
2006). Taking into account that there were very few studies
aimed at examining gene–diet interactions between
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adherence to Mediterranean diet and genetic polymor-
phisms in determining blood pressure, we were interested
in searching for polymorphisms associated with BP which
may also be associated with plasma lipid concentrations, as
well as studying how these associations could be modu-
lated by greater or lesser adherence to the Mediterranean
diet. One of the first genome-wide association studies
(GWAs) focused on BP and carried out in the Framingham
Study (Levy et al. 2007) showed that the intergenic
rs6950982 near the SERPINE1 (serpin peptidase inhibitor,
clade E, member 1) gene was one of the polymorphisms
most significantly associated with BP. This polymorphism
was located in a region that has been linked to arterial
hypertension (Brown et al. 2001; Poli et al. 2000; Eliasson
et al. 1997). Moreover, this region has also been linked to
lipid concentrations (Arya et al. 2002; Duggirala et al.
2000). The SERPINE1 gene, better known by its previous
symbol PAI-1 (plasminogen activator inhibitor 1), located
at chromosome 7q22 (Klinger et al. 1987), is a relevant
marker for fibrinolysis. It has been demonstrated that PAI
protein activity is correlated with plasma insulin and tri-
glyceride (TG) concentrations in subjects with hyperten-
sion (Landin et al. 1990). In addition, one study found an
interactive effect of endogenous angiotensin II and aldo-
sterone on PAI production (Sawathiparnich et al. 2003),
and there are several works analyzing the concurrent
effects of the PAI protein in renal and cardiovascular dis-
eases (Ha et al. 2009). One of the polymorphisms most
studied in the SERPINE1 gene has been the 4G/5G. This
promoter polymorphism has been considered as a risk
factor for cardiovascular diseases (Kohler and Grant 2000;
Li 2012; Gong et al. 2012) and has been associated with
lipid parameters (Ruiz-Quezada et al. 2004; Boncoraglio
et al. 2006; Kinik et al. 2008; Al-Hamodi et al. 2012),
thrombosis (Seguı´ et al. 2000; Gohil et al. 2009; Akhter
et al. 2010), obesity (Berberog˘lu et al. 2006; Kinik et al.
2008), and myocardial infarction (Hindorff et al. 2002;
Ossei-Gerning et al. 1997; Adamski et al. 2009; Gong et al.
2012). In addition, it has also been described as a potential
candidate for hypertension (Kobashi et al. 2009; Martı´nez-
Calatrava et al. 2007; Bjo¨rck et al. 2011; Kim et al. 2012).
However, there are no published studies regarding the
rs6950982 polymorphism in which the association between
this variant and blood pressure and lipid parameters has
been examined. Taking into account that the initial obser-
vation of the association between the rs6950982 near the
SEPINE1 gene and blood pressure in the Framingham
Study has not been replicated in subsequent GWAs, this
may be due to a potential interaction with environmental
factors such as diet that could mask the effect of the
genotype on this trait.
Therefore, our objectives were (1) to study the associ-
ation between the rs6950982 polymorphism in the
SERPINE1 gene and the blood pressure in a high-cardio-
vascular-risk Mediterranean population, (2) to analyze the
association between this polymorphism and lipid parame-
ters, (3) to explore the linkage of disequilibrium between
the rs6950982 and the 4G/5G PAI-1 polymorphisms, and
(4) to analyze the modulation of the rs6950982 effects by
adherence to the Mediterranean diet.
Methods
Subjects and study design
We studied 945 consecutive subjects (340 men and 605
women) aged 55–80 years who participated in the PRE-
vencio´n con DIeta MEDiterra´nea (PREDIMED) Study in the
Valencia Region, Spain, from October 2003 to September
2008. All these subjects had the SERPINE1 polymorphism
determined and valid data for other anthropometric, bio-
chemical and lifestyle variables. The PREDIMED study is a
multi-center clinical trial aimed at assessing the effects of the
Mediterranean diet on the primary prevention of cardiovas-
cular disease. Details of this study have been reported else-
where (Estruch et al. 2006). In this report, we present data of
a cross-sectional analysis at baseline including potential
high-cardiovascular-risk subjects selected by physicians in
primary care centers affiliated to teaching hospitals in the
Valencia region. Eligible subjects were community-dwell-
ing people (55–80 years of age for men; 60–80 years of age
for women) who fulfilled at least one of two criteria: type 2
diabetes; 3 or more cardiovascular risk factors: current
smoking, hypertension (blood pressure C140/90 mmHg or
treatment with antihypertensive drugs), low-density lipo-
protein cholesterol (LDL-C) C160 mg/dl (or treatment with
hypolipidemic drugs), high-density lipoprotein cholesterol
(HDL-C) B40 mg/dl, body mass index (BMI) C25 kg/m2 or
a family history of premature CHD. Exclusion criteria
included a personal history of cardiovascular disease, any
severe chronic illness and drug or alcohol addiction (Estruch
et al. 2006). The Institutional Review Board of the Valencia
University approved the study protocol, and all participants
provided written informed consent.
Anthropometric, clinical, biochemical and lifestyle data
The baseline examination included assessment of standard
cardiovascular risk factors, medication use and socio-
demographic factors. Height and weight were measured
with light clothing and no shoes. BMI was calculated as the
weight (in kg) divided by the height (in m2). Obesity was
defined as a BMI C 30 kg/m2 and overweight as a BMI of
25–29.9 kg/m2 in accordance with World Health Organi-
zation (WHO) criteria. Blood pressure was measured by
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trained personnel using a validated semi-automatic oscil-
lometer (Omron HEM-70CP; Hoofddrop, the Netherlands)
with the subject seated, following the procedures recom-
mended by the Spanish Hypertension Society. Measure-
ments were carried out in triplicate with a 5-min interval
between each, and the mean of these values was recorded.
Fasting blood samples were obtained for each participant
and stored at -80 C until biochemical analyses. Fasting
glucose, total cholesterol (TC), TG, HDL-C and LDL-C
were determined as previously reported (Estruch et al.
2006). Plasma glucose was analyzed by the glucose-oxi-
dase method, triglycerides and TC were measured using
standard enzymatic procedures, and HDL-C concentrations
were estimated after precipitation with phosphotungstic
acid and magnesium chloride. LDL-C concentrations were
estimated with the equation of Friedewald et al. whenever
triglycerides were \400 mg/dl. Physical activity was esti-
mated by the Minnesota Leisure Time Physical Activity
questionnaire (Elosua et al. 2000).
Dietary intake
Food consumption was determined by a previously vali-
dated semi-quantitative 137-item food frequency ques-
tionnaire (Ferna´ndez-Ballart et al. 2010). Energy and
nutrient intake were calculated from Spanish food com-
position tables (Mataix 2003). The baseline examination
also included the administration of a validated 14-item
questionnaire indicating the degree of adherence to the
traditional Mediterranean diet (Schro¨der et al. 2011). Val-
ues of 0 or 1 were assigned to each of 14 dietary compo-
nents. The greater the score obtained from the
questionnaire, the greater the adherence to the Mediterra-
nean diet. We created four groups according to the points
obtained in the questionnaire of adherence to Mediterra-
nean diet; therefore, the first group had the lowest adher-
ence to Mediterranean diet and the fourth group the
highest: Group 1 (G1: 3–6 points, 15.6 %); Group 2 (G2:
7–8 points; 35.2 %); Group 3 (G3: 9–10 points; 32.6 %);
and Group 4 (11–14 points; 16.6 %).
Genetic analyses
Genomic DNA was extracted from buffy coat with the
MagNaPure LC DNA Isolation kit (ROCHE Diagnostics).
The rs6950982 polymorphism in the SERPINE1 gene was
genotyped on a 7900HT Sequence Detection system
(Applied Biosystems) using a fluorescent allelic discrimi-
nation TaqMan assay by standard procedures. For quality
control purposes, 10 % of randomly selected samples were
genotyped a second time. There were no discrepancies
between the two results. Genotype frequencies were con-
sistent with Hardy–Weinberg equilibrium (P = 0.09).
The PAI-1 promoter 4G/5G polymorphism was ana-
lyzed using an allele-specific PCR technique with several
modifications (Grancha et al. 1999). Electrophoresis was
performed in 3 % high-resolution agarose MS-4. Photo-
graphic records were obtained after ethidium bromide
staining.
Statistical analysis
Chi-square tests were used to compare proportions. Tri-
glycerides concentrations were log-transformed for the
statistical analyses. t tests and ANOVA tests were applied
to compare crude means. Dominant, co-dominant and
recessive models of inheritance were first tested to know
the effects of the variant allele. In the analysis for the
additive model, the SERPINE1 polymorphism was con-
sidered as a linear term coded as 0, 1 or 2 depending of the
number of variant alleles, with the homozygote wild type
coded as 0. In this model, each variant allele contributes
additively to the phenotype. Despite this higher effect in
homozygous subjects for the variant allele, for some traits,
a recessive model (AA ? AG) versus GG was more sig-
nificant. Results were presented both for the additive and
for the recessive models. In order to increase statistical
significance, the recessive model was only considered for
the analysis of gene–diet interactions.
Crude models were adjusted for potential confounders
by covariance analysis. Models were adjusted for age,
gender and medications (lipid-lowering and antihyperten-
sive drugs). To study the linkage disequilibrium between
the rs6950982 and the 4G/5G, we used HaploView. To
study gene–diet interactions in determining triglycerides,
we used multivariate linear regression models including
main effects and interaction terms and controls for sex, age
and obesity. The homogeneity of the effects by gender was
also statistically tested. Statistical analyses were performed
with the SPSS package, version 15.0 (SPSS, Chicago, IL).
All tests were two-tailed, and P values \ 0.05 were con-
sidered statistically significant at the nominal value.
Results
General characteristics of the studied population
We studied subjects with high cardiovascular risk from a
Mediterranean population with a mean age of
67.3 ± 6.2 years. Anthropometric, clinical, biochemical
and genetic characteristics of the 945 participants by gen-
der (340 men and 605 women) are presented in Table 1.
Minor allele frequency for the rs6950982 polymorphism in
the SERPINE1 gene was 0.22. Adherence to the Mediter-
ranean diet measured by a Mediterranean diet score
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ranging form 0 (min) to 14 (max) was slightly higher in
males than in females without reaching the statistical sig-
nificance. For statistical analysis, we considered four
groups of increasing adherence to the Mediterranean diet as
detailed in ‘‘Methods’’.
Association between rs6950982 polymorphism,
BP and plasma lipid parameters
Table 2 shows the results of the association between the
SERPINE1 rs6950982 polymorphism and BP and plasma lipid
parameters in the whole population. Mean values for the cor-
responding parameter according to SERPINE1 rs6950982 are
displayed. Crude and multivariate-adjusted P values for each
parameter are shown. First, additive effects were estimated
considering the presence of 0, 1 or 2 variant alleles. In addition,
we estimated the association using a recessive model. We
observed statistically significant association at the nominal
level between the SERPINE1 rs6950982 polymorphism and
total TC, LDL-C and TG in both the additive and the recessive
models. Thus, this SERPINE1 SNP was significantly associ-
ated with TC (AA: 208 ± 41 mg/dl, AG: 210 ± 37, GG:
218 ± 48 mg/dl), LDL-C (AA: 127 ± 36, AG: 131 ± 34,
GG: 136 ± 44 mg/dl) and TG concentrations (AA: 131 ± 69,
AG: 128 ± 67, GG: 154 ± 111 mg/dl), the GG having higher
concentrations after multivariate adjustment for sex, age and
lipid-lowering agents (Padditive = 0.016 and Precessive = 0.011,
Padditive = 0.032 and Precessive = 0.031, Padditive = 0.040 and
Precessive = 0.029, respectively) (Table 2). Although the
association with TG was statistically significant (at nominal
level) under the additive and under the recessive models, when
we examined the differences in means between AA and AG
subjects, we observed that the recessive model for this trait was
more adequate and statistically significant (P = 0.029) than
the additive model (P = 0.40).
No associations were found between the genotype and
the systolic and diastolic BP (Table 2) in the whole pop-
ulation. However, we observed heterogeneity by gender in
these traits and conducted stratified analysis by gender.
Thus, in males (Table 3), after adjustment by age and
antihypertensive agents, the G allele was associated with
higher diastolic BP (AA: 81.5 ± 10.9, AG: 82.1 ± 11.4,
GG: 85.7 ± 10.5 mmHg; P = 0.030) in the additive
model. Moreover, we also observed a significant associa-
tion at the nominal level with higher systolic BP when
the recessive model was considered (AA ? AG: 141.4 ±
6.9 mmHg vs. GG: 149.8 ± 8.0 mmHg; Pl = 0.036).
Moreover, in the stratified analysis, we found that the
association of the SERPINE1 rs6950982 polymorphism
with TC and LDL-C was highly significant in men.
We also analyzed prevalence of hypertension, and we did
not find significant association with the GG genotype
Table 1 Anthropometric, clinical, biochemical, lifestyle and genetic characteristics of participants
Variables Total (n = 945) Male (n = 340) Female (n = 605) P*
Age (years) 67.3 ± 6.2 66.8 ± 5.9 67.60 ± 6.6 0.053
BMI (kg/m2) 30.9 ± 5.1 29.4 ± 4 31.7 ± 5.2 \0.001
TC (mg/dl) 208 ± 40 200 ± 38 212 ± 40 \0.001
HDL-C (mg/dl) 53 ± 14 49 ± 12 56 ± 14 \0.001
LDL-C (mg/dl) 129 ± 36 124 ± 37 131 ± 36 0.004
TG (mg/dl) 131 ± 81 137 ± 74 127 ± 84 0.025
Fasting glucose (mg/dl) 123 ± 40 129 ± 42 119 ± 39 0.001
SBP (mmHg) 147 ± 22 147 ± 21 146 ± 23 0.655
DBP (mmHg) 82 ± 11 82 ± 11 81 ± 11 0.498
MD adherence score 8.48 ± 2.0 8.6 ± 2.0 8.4 ± 2.0 0.097
Diabetes (%) 48.5 56 44.3 0.001
Hypertension (%) 79.7 71.4 84.4 \0.001
Anti-hypertensive agents (%) 66.7 57.3 71.9 \0.001
Current smokers (%) 11.9 26.7 3.6 \0.001
SERPINE1 A [ G (rs6950982) polymorphism 0.09
AA (n = 566) 60.5 61.4 60.9
AG (n = 320) 34.2 31.3 35.0
GG (n = 49) 5.2 7.2 4.1
Values are presented as mean ± standard deviation for continuous variables or % for categorical variables
BMI Body mass index, TC total cholesterol, TG triglyceride, SBP systolic blood pressure, DBP diastolic blood pressure, HDL-C high-density
lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, MD Mediterranean diet
* P value for comparisons between males and females
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(P = 0.332) because of the low prevalence of subjects with-
out hypertension in this high-cardiovascular-risk population.
Linkage disequilibrium of the rs6950982
polymorphism and the 4G/5G in the SERPINE1 gene
Genotype distribution for the 4G/5G SNP was in accordance
with Hardy–Weinberg equilibrium (P = 0.9). The rs6950982
polymorphism and the 4G/5G were slightly in linkage dis-
equilibrium (D0 = 0.719; r2 = 0.167) in this Mediterranean
population, suggesting that the associations between
rs6950982 polymorphism and BP and lipid parameters may
be independent of the 4G/5G polymorphism. However, we
also found that the 5G genotype was significantly associated
with diastolic BP in men (4G ? 4G/5G: 81 ± 10 vs. 5G:
86 ± 13.8 mmHg, P = 0.013). After adjustment by sex, age
and antihypertensive agents, this association remained sta-
tistically significant (P = 0.047). TC and LDL-C concentra-
tions tended to be higher in the 5G genotype, but did not reach
statistical significance (P = 0.282, P = 0.296). No associa-
tions were found for the other parameters analyzed.
Interaction between the rs6950982 polymorphism
and adherence to the Mediterranean diet in determining
TG concentrations
We tested whether adherence to the Mediterranean diet
modified the associations between the rs6950982 and TG
Table 2 Clinical parameters in the whole population (men and women) depending on the rs6950982 SERPINE1 polymorphism
AA (n = 566) AG (n = 320) GG (n = 49) P* P** P^
Age (years) 67.2 ± 6.2 67.6 ± 6.1 68.2 ± 6.8 0.724 0.690 0.256
Score to MD adherence 8.5 ± 2.0 8.4 ± 2.0 8.5 ± 1.8 0.989 0.526 0.968
SBP (mmHg) 146.5 ± 22.0 146.3 ± 23.0 151.1 ± 19.5 0.327 0.956 0.208
DBP (mmHg) 81.2 ± 10.4 82.1 ± 11.7 82.0 ± 11.2 0.129 0.365 0.583
TC (mg/dl) 208 ± 41 210 ± 37 218 ± 48 0.039 0.016 0.011
HDL-C (mg/dl) 53 ± 14 54 ± 13.3 52 ± 13 0.367 0.915 0.911
LDL-C (mg/dl) 127 ± 36 131 ± 34 136 ± 44 0.065 0.032 0.031
TG (mg/dl) 131 ± 69 128 ± 67 154 ± 111 0.013 0.040 0.029
Fasting glucose (mg/dl) 123 ± 41 123 ± 42 122 ± 40 0.847 0.936 0.721
Current smokers (%) 12.2 10.2 16.1 0.778 0.891 0.777
Hypertension (%) 77.8 82.7 83.6 0.139 0.365 0.342
Values are presented as mean ± standard deviation for continuous variables or % for categorical variables
MD Mediterranean diet, SBP systolic blood pressure, DBP diastolic blood pressure, TC total cholesterol, TG triglyceride, FG fasting glucose,
HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol
* P for linear trend (additive effects were estimated including: 0, 1 or 2 variant alleles). Unadjusted analysis
** P value for the additive model adjusted by sex, age and anti-hypertensive agents or lipid-lowering agents
^ P value for recessive effects adjusted by sex, age and anti-hypertensive agents or lipid-lowering agents
P values in bold indicate statistically significant associations (P \ 0.05)
Table 3 Clinical parameters in men depending on the rs6950982 SERPINE1 polymorphism
AA (n = 204) AG (n = 104) GG (n = 24) P* P** P^
MD adherence score 8.7 ± 2.1 8.6 ± 2.0 8.6 ± 1.8 0.860 0.921 0.784
SBP (mmHg) 146.3 ± 20.5 147.3 ± 23.3 155.8 ± 18.5 0.072 0.237 0.036
DBP (mmHg) 81.5 ± 10.9 82.1 ± 11.4 85.7 ± 10.5 0.030 0.130 0.096
TC (mg/dl) 197 ± 36 201 ± 38 225 ± 44 0.002 0.005 0.001
LDL-C (mg/dl) 122 ± 34 126 ± 35 147 ± 45 0.009 0.008 0.002
TG (mg/dl) 136 ± 73 137 ± 69 152 ± 76 0.090 0.377 0.232
Values are presented as mean ± standard deviation for continuous variables
MD Mediterranean diet, SBP systolic blood pressure, DBP diastolic blood pressure, TC total cholesterol, LDL-C low-density lipoprotein
cholesterol, TG triglyceride
* P for linear trend (additive effects were estimated including: 0, 1 or 2 variant alleles). Unadjusted analysis
** P value for the additive model adjusted for age and anti-hypertensive agents or lipid-lowering agents
^ P value for recessive model adjusted for age and anti-hypertensive agents or lipid-lowering agents
P values in bold indicate statistically significant associations (P \ 0.05)
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concentrations according to groups of adherence. Four
categories of adherence to Mediterranean diet were con-
sidered according to the score obtained in the question-
naire, as indicated in ‘‘Methods’’. We found a statistically
significant interaction (nominal P value) between the
SERPINE1 rs6950982 polymorphism and adherence to
Mediterranean diet in determining TG concentrations
(P for interaction: 0.036) (Fig. 1). Means were adjusted by
sex, age, lipid-lowering agents, current smoker and dia-
betes. Among those subjects with lower adherence to
Mediterranean diet (G1–G2–G3), the SERPINE1
rs6950982 polymorphism was significantly associated with
TG concentrations (P = 0.003). In contrast, in the group of
higher adherence to the Mediterranean diet, the GG
genotype was not significantly associated with higher TG
concentrations (P = 0.374).
We also tested the potential gene–diet interaction
between adherence to the Mediterranean diet (four
groups) and the SERPINE1 rs6950982 polymorphism in
determining systolic or diastolic blood pressure. How-
ever, statistically significant interactions were found
(P for interaction between rs6950982 and adherence to
the Mediterranean diet on systolic BP = 0.629; and P for
interaction between rs6950982 and adherence to the
Mediterranean diet on systolic BP = 0.710). We did not
detect any significant interaction with adherence to
Mediterranean Diet when the 4G/5G polymorphism in
determining blood pressure or TG was analyzed.
Discussion
We have investigated the influence of the rs6950982 near
the SERPINE1 gene on BP and lipid parameters in a high-
cardiovascular-risk Mediterranean population. We have
found a statistically significant association between SER-
PINE1 polymorphism and higher diastolic and systolic BP
in men, so replicating previous results from the Framing-
ham Study (Levy et al. 2007) in which additive effects of
the rs6950982 in the SERPINE1 on diastolic BP were
described. Furthermore, we have found statistically sig-
nificant associations between this SERPINE1 polymor-
phism and higher plasma TC, LDL-C and TG
concentrations. In the analysis of gene–diet interactions,
we also found that the association between the rs6950982
in the SERPINE1 and higher TG concentration in GG
subjects is modulated by adherence to the Mediterranean
diet. Thus, when adherence to the Mediterranean diet was
high (G4), we did not observe the increase in TG in GG
subjects. However, when the adherence is low (G1 ?
G2 ? G3), higher TG concentrations were detected in GG
subjects in comparison with carriers of the A allele.
This is the first time that this gene–diet interaction is
reported, and we do not know the potential mechanisms
involved. Recently, it has been published that SERPINE1
gene expression could be under the influence of microR-
NAs (miRNAs) (Marchand et al. 2012). Likewise, another
recent work also suggested that gene–diet interactions as
modulators of different cardiovascular phenotypes may act
in part through creation of a miRNA regulatory sites
(Richardson et al. 2011). More studies are needed to con-
firm this hypothesis.
Apart from the Framingham Study (Levy et al. 2007),
we did not find any other epidemiological study analyzing
the effects of this polymorphism in the SERPINE1 gene on
BP and lipid parameters. However, the 4G/5G polymor-
phism in the promoter of the SERPINE1 gene has been
widely investigated in different studies (Spiroski et al.
2000; Abboud et al. 2010; Rallidis et al. 2010; Lopes et al.
2003; Kobashi et al. 2009, Martı´nez-Calatrava et al. 2007;
Bjo¨rck et al. 2011; Kim et al. 2012; Boncoraglio et al.
2006; Kinik et al. 2008; Al-Hamodi et al. 2012). In this
population, we found that the rs6950982 polymorphism in
the SERPINE1 gene is in slight linkage disequilibrium with
the 4G/5G. Therefore, it seems that the observed effect for
the rs6950982 is more specific for the rs6950982 locus.
However, a linkage disequilibrium effect on blood pressure
with the 4G/5G polymorphism cannot be discarded because
we also have found a statistically significant association at
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Fig. 1 Gene*diet interaction between adherence to the Mediterra-
nean diet (MD) and the rs6950982 polymorphism in the SERPINE1
gene in determining plasma triglycerides. Adjusted means of
triglycerides (TG) are shown depending on the SERPINE1 polymor-
phism according to the strata of adherence to the Mediterranean diet.
Means were adjusted by sex, age, lipid-lowering agents, current
smokers and diabetes. P values for interaction terms between
triglyceride concentrations and SERPINE1 polymorphism were
obtained in the hierarchical multivariate interaction model. TG
concentrations were log-transformed for statistical testing.
G1 ? G2 ? G3 = Group 1, 2 and 3 of adherence to the MD.
G4 = Group 4 with higher adherence to MD
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nominal level between the 4G/5G polymorphism and BP in
our population. There are few studies analyzing the asso-
ciation between 4G/5G genotype and hypertension, and the
results are controversial (Kobashi et al. 2009; Martı´nez-
Calatrava et al. 2007; Bjo¨rck et al. 2011; Kim et al. 2012).
A study analyzing the severe pregnancy-induced hyper-
tension (PIH) suggested that PAI-1 4G/4G alone was not a
risk factor for PIH, but showed positive associations in
combination with other genotypes in other genes (Kobashi
et al. 2009). Other studies showed that fibrinolytic markers
such as PAI-1, tPA, tPA/PAI-1 complex are independently
associated with the development of hypertension, sup-
porting the hypothesis that hypertension may be associated
with impaired fibrinolysis (Tabak et al. 2009). However, no
consistent associations have been found for this SNP.
Other studies analyzing the SERPINE1 4G/5G poly-
morphism have indicated that this polymorphism could
induce alterations in the genetic expression of PAI-1 levels
(Abboud et al. 2010; Schoenhard et al. 2008) affecting the
binding of nuclear proteins and regulating PAI-1 tran-
scription (Dawson et al. 1993; Eriksson et al. 1995). It is
widely accepted that plasma PAI levels are positively
associated with increased risk of artherosclerotic coronary
disease (Abboud et al. 2010). In a case control study, it was
found that 5G carriers and the 5G5G had significantly
higher TC, TG and VLDL concentrations (Ruiz-Quezada
et al. 2004). These results were in line with those found in
our study in carriers of the G allele for the rs6950982
polymorphism. These findings together with our results
illustrate the difficulty of analyzing the genotype–pheno-
type association where environmental factors could mod-
ulate the effects of gene polymorphisms. In this sense,
there are few studies that investigate the gene–environment
interaction involving the PAI-1 polymorphisms. One of
these studies was carried out by Pe´rez-Martı´nez et al.
(2008) on 59 healthy volunteers and showed that carriers of
4G had a decrease in PAI concentrations after a diet rich in
MUFA (monounsaturated fatty acids) compared with a diet
rich in saturated fat and high carbohydrate. However, the
5G had lower PAI concentrations, regardless of the diet.
The results of our study regarding the gene–diet interaction
reveal a modulation of TG concentrations by adherence to
the Mediterranean diet that is a diet rich in MUFA, and a
similar regulation might be involved. However, this
hypothesis is highly speculative, and more research is
needed on this potential mechanism.
On the other hand, one limitation of our study is the
small sample size. Most of our results only reached sta-
tistical significance with nominally significant P values
(P \ 0.05). However, if a correction for multiple compar-
isons were undertaken, taking into account the Bonferroni
approach in which we correct for each one of the traits that
are compared (SBP, DBP, TC, LDL-C, HDL-C and TG),
the P value that we would have to obtain to consider the
results statistically significant would be 0.05/6 = 0.008.
This value is only reached for the association of the
polymorphism with higher TC and LDL-C concentrations
in men. In addition, our results are also statistically sig-
nificant (P \ 0.008) after correction for multiple compar-
isons when we considered the modulation by the adherence
to the Mediterranean diet. Thus, the association between
the rs6950982 polymorphism and plasma TG concentra-
tions was statistically significant (P = 0.003) in the three
groups of less adherence to the Mediterranean diet,
whereas we did not find association (P [ 0.05) in the group
of higher adherence to the Mediterranean diet.
In conclusion, we have found that rs6950982 near the
SERPINE1 gene is associated with TC, LDL-C, TG and BP
(in men) in a high risk Mediterranean population and that
the adherence to Mediterranean diet may modulate the
association with TG. However, taking into account that this
is the first time that this interaction is reported as well as
sample size limitations, more studies are required to con-
firm our findings and to better understand the mechanism
involved in this association.
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